China and the European Union are regulating AI ethics. The mandate for medtech design teams: build AI-powered products that meet ethics standards and inspire user trust.
Tags
Archive: health
3 UX Trends Shaping Healthcare in 2021
As users continue to establish trust in emerging technologies, UX research can pave the way to a better experience with more inclusive design, better designed telehealth applications, and increased AR and VR integrations.
Physicians and specialists weigh in on telehealth improvements
HCP focus group revealed valuable design insights for telehealth and EMR systems.
UX research reveals common concerns from HCPs about telehealth technology
Our research has shown a trend in healthcare provider feedback regarding mHealth alerts and features. While generally positive about the concept, liability is top of mind with this user group and common questions were raised during testing.
Bold Insight’s Gavin Lew to highlight medical devices and human factors at Intellus Worldwide Summit
Gavin Lew, Managing Director of Bold Insight, will present at the 2019 Intellus Worldwide Summit Insights Evolution in Philadelphia, Pennsylvania on May 20, 2019. In his talk, Medical Devices & the Human Factors of Health, Lew will describe the regulatory...
Bold Insight awarded ISO 9001:2015 certification
Bold Insight, a user experience (UX) and human factors (HF) research agency, is proud to be awarded ISO 9001:2015 certification from NSF-ISR. Achieving certification is a demanding process that includes a rigorous audit to demonstrate Bold Insight’s conformance to...
Bold Insight awarded Best Human Factors Research Agency of 2018
Bold Insight is proud to be recognized by the Global Business Insight Awards as the Best Human Factors Research Agency of 2018. The Global Business Insight Awards celebrate business leadership and innovation across a wide range of sectors. Bold Insight was selected...
Bold Insight’s Korey Johnson co-presents human factors training to members of FDA’s DMEPA
Representatives from the Human Factors and Ergonomics Society (HFES) provided a two-day training course on human factors science, user-centered design principles, and root cause analysis on September 25-26, 2018 at the Food and Drug Administration’s (FDA) White Oak...
Bold Insight connects with human factors community at HFES 2018
A leader in the medical device human factors industry, Bold Insight sponsored this year’s Human Factors and Ergonomics Society (HFES) International Annual Meeting to connect with HF/E colleagues and young professionals interested in pursuing a career in the space. The...
Bold Insight to exhibit at Human Factors Excellence for Medical Device Design conference
Bold Insight will exhibit at the 4th Annual Human Factors Excellence for Medical Device Design on August 1-2, 2018 in Minneapolis, Minnesota. Bringing together human factors engineering and user experience (UX) professionals, the conference will highlight emerging...
Reclassifying diabetes: 3 implications for product design
Recent research suggests that reclassifying diabetes may allow for the development of more targeted diabetes treatments. This could present opportunities to design these treatments to maximize patient safety and experience.
5 takeaways for human factors practitioners from the HFES Health Care Symposium FDA workshops
Healthcare symposium provides clarity for interpretation of FDA guidance documents related to human factors engineering.
Bold Insight’s Korey Johnson chairs usability session at HFES Health Care Symposium
Actively involved in the medical device human factors community, Korey Johnson, Managing Director of Bold Insight, will chair a session in the Medical and Drug-Delivery Devices Track at this year’s International Symposium on Human Factors and Ergonomics in Health...
The time for a better UX in digital therapeutics is now
If history has shown that payer behavior tends to shift once a critical mass has been achieved, and we are on the precipice of achieving that critical mass for digital therapeutics, having a “user friendly solution” is about to replace “having a reimbursable solution” as the #1 factor affecting physician prescribing behavior.